KC
ARRY

Kepos Capital’s Array Biopharma Inc ARRY Stock Holding History

Kepos Capital’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-104,545
Closed -$1.59M – 443
2018
Q3 		$1.59M Hold
104,545
– – 0.08% 187
2018
Q2 		$1.75M Buy
+104,545
New +$1.66M 0.09% 173

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Kepos Capital's ARRY Position: Q4 2018 in Review

Kepos Capital sold out of Array Biopharma Inc (ARRY) in Q4 2018, closing a stake of 104,545 shares — an estimated $1.59M sold.

Kepos Capital first reported a position in ARRY in Q2 2018 and held it in 2 quarters. The position peaked at $1.75M in Q2 2018. 236 funds tracked by Wall St. Rank hold ARRY as of Q4 2018.

  • Kepos Capital reported no remaining Array Biopharma Inc position as of Q4 2018 after selling out during the quarter.
  • Kepos Capital sold 104,545 Array Biopharma Inc shares in Q4 2018, an estimated $1.59M.
  • Kepos Capital first reported a position in Array Biopharma Inc in Q2 2018 and held it in 2 quarters.
  • Kepos Capital's Array Biopharma Inc position peaked at $1.75M in Q2 2018.
  • 236 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2018.

Based on Kepos Capital's 13F filing for Q4 2018, filed 13 Feb 2019.